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Perinatal asphyxia (PA) is the medical condition elicited by the impairment of exchange 
of the respiratory gases – resulting hypoxemia and hypercapnia – during birth to a newborn 
infant that lasts long enough to cause damage to the infant’s organs, including the heart, lungs, 
liver, guts, kidneys and the brain. It affects 1 to 6 newborns per 1000 full-term live births and 
represents one of the most common causes of neonatal death. 
The hypoxic-ischemic encephalopathy (HIE) is a sub-set of cases of neonatal 
encephalopathy with a good evidence of a recent hypoxic-ischemic cause (including but not 
limited to PA), characterized as a clinically defined syndrome of disturbed neurological 
function in the earliest days of life in the term infant, manifested by difficulty with initiating 
and maintaining respiration, alterations in muscle of tone and reflexes, sleep-wakefulness cycle 
disorders including coma, and often by epileptic seizures. The prognosis depends on the 
severity of the PA. HIE cases can be graded into 3 clinical stages: mild, moderate and severe 
encephalopathy according to the Sarnat scoring system. Whereas a few infants survive even 
severe HIE without handicap, many of them develop life-long complications: 80% of dyskinetic 
cerebral palsy can be associated to PA at term, furthermore, hearing and visual loss, learning 
difficulties, memory impairments, attention deficits, hyperactivity, increased risk of 
schizophrenia are reported in children following PA/HIE.  
 Although most of the detailed epidemiological studies are based on data of high-income 
developed countries, unquestionably the burden of this disease is the most severe in the 
developing countries. Lack of modern healthcare results in 8 times higher mortality in low 
income countries than in the developed regions. 
We need to strive for an effective, reliable and inexpensive therapeutic intervention to 
alleviate the threats of PA/HIE. 
Currently, therapeutic whole-body hypothermia is the accepted treatment of PA/HIE 
patients, however, hypothermia cannot offer full neuroprotection and may result in unwanted 
effects such as bradycardia, hypotension, and thrombogenesis. The treatment requires  a quite 
expensive cooling/heating equipment, as the cooling-rewarming procedure should be tightly 
controlled and therefore it is unavailable in many underprivileged medical institutions. 
Therefore, further studies aim to establish an alternative/ completive therapy, such as ventilation 
with neuroprotective gases. 
 We chose molecular hydrogen (H2) as a putative neuroprotective agent to combat 
PA/HIE based on the Nature report of Ohsawa et al., they found H2 an ex vivo antioxidant and 
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an in vivo neuroprotectant in an adult stroke rat model. H2 is a small membrane-soluble gas 
molecule, therefore inhaled H2 can easily penetrate the blood-brain barrier. Indeed, H2 
inhalation has been successfully used for measuring cerebral blood flow (the hydrogen 
clearance technique) since the 1960’s.  The optimally neuroprotective 2% H2 concentration also 
used in our studies is expected to result in approximately 10-20 µmol/l brain H2 levels in rats 
and humans alike. The neuroprotective effect of H2 may be partly based on its antioxidant 
nature: it has been reported that H2 selectively eliminates free radicals such as OH· and ONOO, 
furthermore, H2 is reported to also have a “mitohormetic” effect, increasing the expression of 
anti-oxidative enzymes underlying the Nrf2-pathway, but there can be further yet unknown 
pharmacological targets.  H2 is readily available, inexpensive and easy to apply, in 
neuroprotective concentrations not flammable, and human tolerance studies also prove its 
applicability. 
To study the pathophysiology of PA/HIE, and to test neuroprotective strategies, our 
Experimental Neonatology Research Group developed newborn pig PA/HIE models. The 
newborn piglet is an accepted large animal model of the term human neonates as the brain of 
the newborn piglet has similarly gyrencephalic structure, its developmental state and metabolic 
rate are matching around birth in the two species. 
Our group performed previously two sets of subacute (24 h survival) experiments to 
study the neuroprotective potential of H2 against PA/HIE in term newborn piglets: in the first 
study PA was induced with 8-minute long trachea-occlusion, in the second study with 
20-minute long ventilation of a hypoxic-hypercapnic gas mixture, completed with respective 
time control and H2 treated asphyxia groups.  
During the whole experiment the physiological parameters (heart rate, arterial blood 
pressure, O2 saturation, core temperature), blood gas and blood glucose levels at baseline were 
always in the physiological range in all animals, except the duration of asphyxia. Our meta-
analysis showed that by the end of the asphyxia, acidosis, hypercapnia, and hyperglycemia was 
more severe in the 20-min long PA model. Hematoxylin-eosin stained sections revealed 
significantly more severe cerebrocortical lesion in the 20-min long asphyxiated animals. In a 
similar fashion, more severe neuronal injury was observed in the hippocampus and in the basal 
ganglia as well. In summary, we can state that 8 min trachea-occlusion elicited mild-moderate 
whereas 20 min asphyxia resulted moderate-severe HIE. Thus, the 20-min long PA was more 
appropriate to demonstrate the neuroprotective potential of H2. 
Cyclooxygenases (COXs) are the rate-limiting enzymes catalysing the first committing 
step of prostaglandin secretion. There have been at least two COX isoforms described in the 
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central nervous system, COX-1 and COX-2. They are both membrane-associated enzymes and 
they maintain 63% homology in their amino acid sequence. Although they have similar catalytic 
activity, they differ in their pharmacological properties, as well as in cellular and tissue 
distribution. Both COX-1 and COX-2 are constitutively expressed in the central nervous 
system, furthermore, COX-2 proved to be the dominant isoform of COXs in the neonatal brain, 
providing up to 80% of the total brain COX activity. Whereas COX-1 is constitutively 
expressed in most brain regions, COX-2 is especially enriched in the hippocampus and the 
cortex. COX-2 plays a role in the modulation of neuronal activity and the neurovascular 
coupling. Additionally, expression of COX-2 is well-known to be upregulated by various brain 
disorders including brain trauma, cerebral ischemia, and proinflammatory insults.  Several 
studies have shown the efficacy of pharmacological COX-2 inhibition to limit neuronal injury, 
for instance the decrease of stroke volume after experimental ischemia. 
During prostaglandin production, reactive oxygen species (ROS) are co-released by 
COX-2, which are eliminated by endogenous antioxidants under physiological conditions. 
Neonates are particularly sensitive for oxidative stress by ROS due their organs’ structural and 
functional immaturity, the overloading of aerobic metabolism with rapidly growing energy 
demand, the reduced ability to induce efficient homeostatic mechanisms, as well as the lack of 
effective antioxidant systems that mature during the first year of life in human neonates.  
 
COX-2 has an undeniable role in the pathogenesis of HIE. A study showed that the 
administration of COX-2 inhibitors provided neuroprotection in a rat HIE model. Additionally, 
human neonatal brain ischemia has been also linked to high level of neuronal COX-2 expression 
by a human autopsy study.  Therefore, the role of COX-2 in the pathomechanism of HIE could 
be best investigated in a translational large animal model that could also be used to establish 
neuroprotective treatments. 
COX-2 has been extensively monitored in newborn piglets as well. It has been shown 
that anoxic stress increases COX-2 but not COX-1 mRNA and protein levels both in the 
cerebral vascular endothelium as well as in the cortical and hippocampal neurons, meanwhile 
this elevation was not successfully evoked by asphyxia within 2-8 hours of survival. The 
regional distribution of COX-2 immunopositive neurons in piglet brain was already described 
by our group, however within 4 hours following trachea-occlusion no change in COX-2 
immunopositivity occurred. This study raised the question about whether a more effective 
asphyxia induction or longer time window of observation was needed. 
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Neuroinflammation likely plays an important role in the pathomechanism of neuronal 
injury during PA/HIE, and the role of microglial cells appears to be crucial, However, microglia 
have dual, contrasting roles in neuroinflammation. The microglial activation and effect is 
influenced by the mechanism, location, and severity of the injury and the age at which the injury 
occurs, Previous reports about microglial activation in the piglet model of PA/HIE were 
inconsistent, therefore it is necessary to describe the microglial activation in our recent PA/HIE 
model. 
  
While PA/HIE causes severe neuronal damage, many, sometimes the majority of the 
neurons still survive the insult. As the antiapoptotic mechanisms work in the favour of 
preserving the neurons, therefore their stimulation can be valid potential targets of 
neuroprotective strategies.  
Brain-derived neurotrophic factor (BDNF) belongs to the neurotrophic factor family and 
plays an important role in neuronal development and maturation in the central nervous system. 
The neuroprotective effects of BDNF are mediated by the mitogen-activated protein kinase 
(MAPK) or phosphatidylinositide-3-kinase (PI-3-K) pathway. The activation of these pathways 
can be described with the activation – phosphorylation – level of protein kinase-B (Akt) and 
signal related kinase (ERK). Intracerebroventricular administration of BDNF to postnatal day 
7 rats elevated the phosphorylation level of ERK and Akt kinases. Pharmacological inhibition 
of ERK increased the tissue loss after the hypoxic-ischemic insult in rodents, however little is 
known about the activation of these pathways in a newborn large animal model after hypoxic-
ischemic injury. 
 
To better describe our model, and also to tackle some of the cellular events of the 
developing HIE, our aims were to answer the following questions: 
1.) Regional differences in neuronal COX-2 expression have been previously reported.  We 
therefore asked if the 24 h observation of the anesthetized animals would per se 
influence the percentage of COX-2 immunopositive neurons? 
2.) Does PA induce neuronal COX-2 after 24 hours of survival? Are there any regional 
differences in the response to PA? 
3.) Is there any correlation between the percentage of COX-2 immunopositive neurons and 
the severity of the neuronal lesion? 
4.) Is there any correlation between the percentage of COX-2 immunopositive neurons and 
the oxidative damage of neurons? 
~ 5 ~ 
 
 
5.) Can microglial activation be demonstrated in our PA/HIE model? Is there any 
correlation between the percentage of COX-2 immunopositive neurons and the degree 
of microglial activation? 
6.) Can the neuroprotective H2 treatment interfere with the effect of PA on the percentage 
of COX-2 immunopositive neurons or affect the microglial response? 
7.) Can the activation of the Akt and ERK play an important role in neuronal survival in 
24-48 hours after PA?  
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MATERIALS AND METHODS 
All procedures were approved by the Animal Care and Use Committee of the University of 
Szeged. Animal care and handling were in accordance with the National Institutes of Health 
guidelines. 
1. Analysis of neuronal damage and neuroinflammation with immunohistochemistry 
For immunohistochemistry, we used the brain samples of newborn male Large-White 
piglets (age < 24 h at beginning of experiments, body weight: 1.5-2.5 kg, n=47) obtained mainly 
from the previous studies. The major difference between the two studies was the induction 
method and the duration of PA: asphyxia was elicited by 8 minutes of trachea-occlusion and 
suspended ventilation in the first, and by 20-minute-long ventilation with hypoxic-hypercapnic 
gas mixture (6% O2, 20% CO2) in the second study. In both studies, the asphyxia group was 
complimented with time control and H2-treated asphyxia groups (n=7-7). A naïve group of 
animals was (n=5) also added: animals were sedated with sodium thiopental (45 mg/kg, ip.) and 
their brain were perfused with physiological saline through the catheterized common carotid 
arteries, then harvested for further experiments. Before histological experiments, the brains 
were immersion-fixed with 4%, 4°C paraformaldehyde for 2 weeks. The tissues were paraffin-
embedded and 4 µm slices were prepared. To determine neuronal lesion, we performed 
hematoxylin-eosin staining followed by cell counting or neuropathological scoring. 
Immunohistochemistry was performed with automatized immunostainer. Slides were 
digitalized. We determined the ratio of COX-2 immunopositive neurons with cell counting in 
the frontal, parietal, temporal and occipital cortices, as well as in the hippocampal CA1, CA3 
regions and dentate gyrus, in the thalamus, basal ganglia and among cerebellar Purkinje-cells. 
We also counted the number of 8-hydroxi-2’-deoxyguanozine (8-OHdG) immunopositive 
neuronal nuclei in the parietal cortex. 
We also investigated the microglial activation in the parietal cortex, characterized with the 
so-called ramification index, which considers the number of Iba-1 positive microglial cell 
bodies within a grid and the microglial processes crossing the gridlines. As the activated 
microglia can be identified with reduced processes and amoeboid-like shape, the lower the 
ramification index is, the more activated the microglia are. 
  




2. Investigation of neuroprotective signalling pathways with Western blot analysis 
We examined the activation of Akt and ERK signalling pathways at 24 and 48 hours 
following 20-min asphyxia in cortical and subcortical brain regions as well, then compared the 
values to time control and naïve animals (n=12). The total and phosphorylated protein levels 
were determined with Western blot analysis. 
To double-check our results, we topically administered specific ERK and Akt kinase 
inhibitors: U0126 and A-6730, respectively (n=4-4). 
 
  




1. The effect of anesthesia on neuronal COX-2 expression 
Neuronal COX-2 expression showed marked regional differences: in the naïve animals the 
highest percentage of COX-2 positive neurons could be observed in the frontal and parietal 
cortices similar to our previous results in time controls at 4 hours of survival, as described 
previously. However, this regional expression pattern appeared markedly changed in the 24h 
time controls, as the COX-2 expression was significantly reduced in all neocortical regions 
compared to naïve or 4h survival animals.  This reduction was found limited to the neocortex: 
the ratio of COX-2 immunopositive neurons remained unchanged in the hippocampus. 
 
2. Effect of asphyxia and H2 ventilation on neuronal COX-2 expression 
In the brain regions obtained from the study of 8-minute-long asphyxia, there was no 
significant alteration in neuronal COX-2 expression as no difference was noted between the 
time control and asphyxiated groups in any of the observed regions. In contrast, 20-minute-long 
asphyxia elicited significant increases in neuronal COX-2 immunopositivity in the parietal and 
occipital cortices, as well as in the hippocampal CA3 region. Furthermore, a tendency of 
asphyxia-induced elevation in COX-2 immunopositive neurons could also be observed in the 
frontal and temporal cortices and in the basal ganglia too, albeit these changes did not reach 
statistical significance in these regions. In the H2-treated group, despite exposure to the same 
level of asphyxia, the ratio of COX-2 immunopositive cells was similar to the time control 
group. In contrast to the CA3 subfield, the hippocampal CA1 region and the dentate gyrus 
displayed low percentage of COX-2 immunopositive neurons in time controls, and the ratio of 
immunopositive neurons were unchanged by asphyxia, they were similar in all three groups. In 
a similar fashion, COX-2 was present in about 30% of the cerebellar Purkinje cells in all 
experimental groups.  
Notably, strong COX-2 immunopositive areas were only recorded in the asphyxia group of 
animals. 
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3. Assessment of correlation between neuronal COX-2 expression and neuronal 
damage 
As neuronal COX-2 expression was affected by 20-minute-long asphyxia only, we 
performed all subsequent studies on these animals.  We first investigated whether the ratio of 
COX-2 immunopositive neurons correlated with the previously determined neuropathology 
scores, higher scores reflecting more severe neuronal damage in the cortex. We found no 
correlation between the neuropathology scores and neuronal COX-2 expression; however, we 
could clearly identify 3 expression patterns: low neuropathology scores were always associated 
with low-moderate levels of neuronal COX-2 expressions; high neuropathology scores were 
associated either with high or with low COX-2 expression levels.  Notably, low neuropathology 
score never coincided with high COX-2 expression level. 
 
4. Correlation between neuronal COX-2 expression and oxidative DNA damage 
In the parietal cortex, 20-minute-long asphyxia significantly increased the ratio of 8-OHdG 
immunopositive neuronal nuclei compared to both the time control and the H2-treated asphyxia 
group indicating oxidative stress induced by asphyxia and the mitigating effect of molecular 
H2. By assessing the correlation between the ratios of COX-2 and 8-OHdG immunopositive 
neurons, we found a marked tendency, either considering data from all groups or from the 
20 min asphyxia group alone. 
 
5. Microglial activation and its correlation with COX-2 expression 
The Iba-1 immunohistochemistry visualized the distribution and morphology of microglia 
in the parietal cortex.  Microglial activation is associated with reduced branching and assuming 
an amoeboid shape, and this change was quantified by ramification index determination. We 
found that ramification index was significantly lower – indicating microglial activation - in the 
group subjected to 20 min asphyxia, than in the time control group. However, there was no 
statistical difference between the time controls and the H2-treated asphyxiated animals. When 
considering all data points, RI showed no correlation with neuronal COX-2 expression, but 
when regarding exclusively the 20 min asphyxia group significant negative correlation was 
observed. 
  




6. Activation of Akt and ERK signalling pathways 
The Akt and ERK kisases showed high activational state in the frontoparietal cortex 
considering the naïve, the time control and asphyxia grops as well, following the asphyxia with 
24 or 48 hours too.  
We successfully decreased the Akt and ERK phosphorylation with topical administration 
of specific inhibitors, compared to the contralateral untreated side of the cortex. 
The Akt and ERK activation was similarly high in hippocampal and subcortical brain 
samples, as in the frontoparietal cortex in all experimental groups. 
  




The major findings of the present study are as follows:  
1) region-specific neuronal COX-2 expression in the neocortical areas is maintained at 4 hours 
of survival, but greatly reduced in 24-h anaesthetized time controls;  
2) 20-min, but not 8-min long PA can significantly elevate the number of COX-2 positive 
neurons in the neocortex and the hippocampal CA3 subfield but not in the assessed subcortical 
areas or other hippocampal structures;  
3) high ratios of COX-2 immunopositive neurons are always associated with severe neuronal 
lesion;  
4) the ratio of COX-2 expressing neurons correlates with the oxidative damage of the neurons 
in the parietal cortex; 
5) microglial activation can be detected in our HIE model already after 24 hours of survival in 
the parietal cortex, and the ratio of COX-2 immunopositive neurons correlates with microglial 
activation; 
6) the neuroprotective H2 administration prevents the upregulation of neuronal COX-2 
expression in all sensitive brain regions, reduces oxidative damage, and alleviates microglial 
activation after PA; 
7) both ERK and Akt are constitutively phosphorylated/ active in the cerebral cortex and all 
other assessed brain regions of newborn pigs irrespective of the length of anaesthesia and/or 
exposure to asphyxia; meanwhile we proved that the high cerebrocortical ERK and Akt 
phosphorylation levels under normoxic conditions can be in vivo modulated by specific 
inhibitors. 
 
We are the first to describe the induction of neuronal COX-2 expression following 
asphyxia in a translational subacute piglet PA/HIE model.  Previously, we extensively 
characterized the effect of 20-min asphyxia elicited in newborn piglets by ventilation with a 
hypoxic-hypercapnic gas mixture on hemodynamics, blood gases, metabolites, 
electroencephalogram and neuropathology.  The applied insult resulted in alterations that 
matched both human pathology and corresponded to moderate to severe HIE. Our present 
results elucidated the confounding results from previous studies in which elevations in COX-2 
levels were reported after 10 min of global cerebral ischemia but not 10 min of asphyxia.  Our 
current results suggest that this reported difference was due to the more severe 
hypoxic/ischemic insult elicited by global cerebral ischemia, and in the present study, the longer 
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asphyxia duration rather than the shorter treatment elicited conditions similar to those observed 
with global ischemia, which resulted in the upregulation of COX-2.  
In the present study, neuronal COX-2 abundance was conspicuously reduced in all 
neocortical areas of the 24 h time control animals compared to the values previously reported 
in our 4 h survival study or compared to naïve animals. The decreased number of COX-2-
expressing neurons may be in part explained by the inactivation of cortex due to anaesthesia, 
as COX-2 expression is stimulated by neuronal activity. The applied anaesthetic/analgesic 
drugs could exert an inhibitory effect on COX-2 expression by interacting with the nuclear 
transcription factor NF-κB signalling pathway, which is a well-known transcriptional regulator 
of COX-2. Although morphine has been reported to have ambiguous stimulatory and inhibitory 
effects on NF-κB activation, midazolam is unequivocally known to inhibit the NF-κB pathway. 
The applied anaesthetic regimen was chosen to enhance the translational potential of our animal 
model, as morphine/midazolam analgesia/sedation is routinely used in the management of 
human neonates affected by PA/HIE.  Furthermore, experimental data suggested that morphine 
analgesia may be an important permissive factor by allowing neuroprotective therapies such as 
therapeutic hypothermia to be effective; mild hypothermia failed to exhibit neuroprotection in 
the absence of anaesthesia and analgesia in newborn pigs.  
Our findings suggested a time-dependent role of COX-2-derived ROS and prostanoids 
in the pathomechanism of HIE development in different brain regions, as COX-2 activity-
dependent neuronal injury in the early reventilation/ reoxygenation phase will be most likely 
pronounced in regions with high baseline COX-2 expression (especially the frontoparietal 
neocortex). However, in the delayed secondary energy failure phase, COX-2 will likely remain 
a more important pathogenic factor for neuronal injury in those areas where the asphyxia-
induced elevation dominates the anaesthesia-induced depression of COX-2 levels. 
The present data thus suggested that at least in the neocortical areas, two factors affect 
neuronal COX-2 abundance. Long-term anaesthesia tends to decrease the enzyme levels, 
whereas asphyxia elevates them. Both the increase in COX-2 levels and the increase in the level 
of neuronal injury were variable in the piglets subjected to asphyxia, in accordance with the 
spectrum of human HIE severity. We found that very high percentages of COX-2-
immunopositive neurons were inevitably accompanied by the most severe types of cortical 
neuronal damage. In some cases, however, similarly high neuropathology scores coincided with 
rather low COX-2 immunopositivity.  These areas may perhaps represent those severely 
damaged areas where the hypoxia/ischemia-induced translational blockade might have 
prevented the expression of COX-2. Thus, the areas displaying very high neuronal COX-2 
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levels may represent those areas that were still able after asphyxia to translate new proteins, and 
the deleterious effects of COX-2 may have contributed most in these areas to the observed 
neuronal damage. 
 We assessed the effect of a neuroprotective (2.1%) concentration of H2 on neuronal 
COX-2 expression. In addition to our previous studies, this concentration was found to be 
neuroprotective in a number of other disease models as well.  
 Our current results concerning the correlation of nuclear 8-OHdG immunoreactivity 
with COX-2 expression and the remarkable efficacy of molecular H2 inhalation to attenuate 
elevations in both 8-OHdG and COX-2 levels after asphyxia suggest a role for ROS in the 
mechanism of COX-2 expression. 8-OHdG is used as a biomarker of oxidative modifications 
to DNA: elevations in the number of 8-OHdG-positive nuclei indirectly indicate significant 
oxidative stress imposed by hydroxyl radicals. Importantly, as molecular H2 was originally 
described as a selective hydroxyl radical scavenger, the efficacy of H2 to attenuate elevations 
in 8-OHdG levels after asphyxia further confirms the presence of significant oxidative stress 
perhaps characterized by significant production of hydroxyl radicals in our present PA/HIE 
piglet model. The connection between this oxidative stress and the observed induction of 
COX-2 expression may be the activation of NF-κB, which is a transcription factor known to be 
induced by ROS and inhibited by antioxidants. The general physiological functions of NF-κB 
include the regulation of apoptosis, cell growth, cellular stress responses and intracellular 
signalling. NF-κB affects various brain functions as well as neuronal development, 
inflammation and neurodegeneration. Brain injury has been shown to increase NF-κB activity. 
The COX-2 gene is a neuronal target of NF-κB, and therefore the asphyxia-induced increase in 
neuronal COX-2 expression is very likely mediated via NF-κB. A recent report in neonatal rats 
demonstrated reduced NF-κB activation in H2-treated rat pups, which lends experimental 
support to our hypothesis.  
We found that microglia were activated by asphyxia only but not by asphyxia followed 
by H2. As microglial activation has also been reported to be accompanied by NF-κB activation, 
hydroxyl radicals may have activated the microglia by promoting NF-κB activity in the present 
study. 
 Another possible neuroprotective therapy would be the prevention of neuronal cell death 
through the activation of antiapoptotic signalization. Both endogenous and exogenous BDNF 
could exert neuroprotection: BDNF mRNA levels detected at 48 h survival were significantly 
increased in all brain areas compared to naïve animals in a newborn piglet HIE model. 
Furthermore, exogenous BDNF was found neuroprotective in a rat HIE model; administration 
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of BDNF to postnatal day 7 rat pups was causally linked to pronounced and rapid increases in 
the phosphorylation/activation of ERK and Akt kinases. Pharmacological modulation of Akt 
and ERK kinases also supported their neuroprotective role. In our current piglet PA/HIE model 
ERK and Akt phosphorylation was virtually complete also in the cortex of untreated naïve 
animals, and it was not changed significantly for at least 48 h either in the normoxic time 
controls or the animals subjected to PA. This high degree of baseline phosphorylation/activation 
of untreated animals was also observed in virtually all of the assessed brain regions. Similarly, 
high phosphorylation levels were maintained also at 48 h after asphyxia. Given the high basic 
activation of these neuroprotective kinases, H2 was ineffective to accomplish neuroprotection 
via Akt or ERK pathway. Our pharmacological experiments proved that our results cannot be 
simply attributed to technical limitations. We could show in the neocortex, where local 
pharmacological treatment through the closed cranial window was possible that the MEK and 
Akt1/2 kinase inhibitors could reduce rapidly and statistically significantly the ratio of the 
phosphorylated forms of ERK and Akt, respectively. The background of this substantial 
difference is unknown, but one can assume to be associated with the fact that the piglets in the 
present study were indeed in the perinatal period: they were all born < 24 h before the 
experiments. Vaginal delivery even under physiological conditions is associated with mild 
asphyxia and perhaps this physiological amount of cerebral hypoxia is enough to trigger the 
observed activation of ERK and Akt. BDNF acts as a participant of neuroendocrine cascade of 
delivery, thus its level is elevated – measured in umbilical cord samples – and may interact 
through Akt and ERK signalisation. This situation may be in sharp contrast with most of the 
neonatal rodent HIE models. In these models P7–P8 pups are used because brain maturity is 
closest to the term human baby at this postnatal age. However, our results suggest that in these 
models the effects of delivery on cerebral function may have already likely faded. These results 
question the efficacy of therapeutic interventions aiming to activate these antiapoptotic 
signalling pathways to obtain neuroprotection. This suggestion is supported by the findings of  
Robertson et al., who studied melatonin-induced neuroprotection in a very similar newborn 
piglet 48 h survival HIE model. Although melatonin was found neuroprotective, however, 
significant anti-apoptotic effect of melatonin could not be shown in the cerebral cortex. These 
results support the findings of Yue et al. describing that the cell death following hypoxia-
ischemia is predominantly caused by necrosis. 
 




 In newborn pigs, PA induces neuronal COX-2 expression that depends on the severity 
of PA and shows marked region-dependence as well.  We also showed that neuronal COX-2 
expression is also dependent on the duration of anaesthesia in neocortical areas.  
 Neuronal COX-2 expression correlates with the oxidative damage of the neurons as well 
as the microglial activation. 
 The H2-treatment – likely through its antioxidant activity – alleviates the PA-induced 
elevation of neuronal COX-2 expression, the oxidative stress and the microglial activation.  
 The antiapoptotic signalling pathways appear to be constitutively active in our model, 
in accordance with the suggestion that the PA-induced neuronal loss is mostly caused by 
necrosis in the observed period of HIE. 
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